Clinical features, diagnosis, and management of dasatinib-induced nephrotic syndrome.
Invest New Drugs
; 40(5): 1153-1159, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-35867286
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Glomerulosclerosis, Focal Segmental
/
Nephrotic Syndrome
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Invest New Drugs
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
United States